(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Earnings Countdown: NVIDIA, Medtronic, and Analog Devices Take the Stage

  • November 18th, 2023
  • 478 views

On Tuesday, November 21, several companies are set to report their financial results, including:

NVIDIA Corporation (Nasdaq: NVDA), a global technology leader in graphics processing units (GPUs) and AI, is scheduled to release its financial results for the third quarter of fiscal year 2024 after the market closes. 

Analysts anticipate earnings per share (EPS) of $3.36 on revenue totaling $16.16 billion.

$NVDA closed at $492.98 on Friday, down $1.82 (-0.37%).

Medtronic plc (NYSE: MDT), a leading medical technology company, will report financial results for its second quarter of fiscal year 2024 before the market opens. 

The consensus EPS estimate stands at $1.18, complemented by revenue amounting to $7.92 billion.

On Friday, $MDT closed at $74.76, reflecting a slight decrease of $0.12 (-0.16%).

Analog Devices, Inc. (Nasdaq: ADI), a key player in the semiconductor industry, will release financial results for its fourth quarter fiscal year 2023 prior to the market opening. 

Analysts forecast an EPS of $2.00 on revenue of $2.7 billion.

$ADI closed at $183.05 on Friday, up $3.21 (+1.78%).

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13